JennyCChangMD

Clinical Trials

• Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10

  Active, not recruiting

  Phase 3

• The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer Start of enrollment: 2010 Jun 01

  Unknown status

  Phase 1

• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16

  Completed

  Not Applicable

• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06

  Active, not recruiting

  Phase 3

• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) Start of enrollment: 2011 Sep 01

  Completed

  Phase 2

• Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer Start of enrollment: 2013 Feb 01

  Terminated

  Phase 2

• NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer Start of enrollment: 2013 Jul 01

  Completed

  Phase 2

• PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer Start of enrollment: 2012 Jul 01

  Withdrawn

  Phase 2

• Olive Oil for High Risk Breast Cancer Prevention in Women Start of enrollment: 2013 Dec 01

  Completed

  Phase 2, Phase 3

• T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• Emotions Immunology and Breast Cancer Start of enrollment: 2015 Nov 23

  Completed

  Not Applicable

• Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer Start of enrollment: 2021 Mar 17

  Suspended

  Phase 2

• Combined Immunotherapies in Metastatic ER+ Breast Cancer Start of enrollment: 2020 Nov 12

  Recruiting

  Phase 2

• Join now to see all